| Molecular formula | C36H48N6O7 |
| Molecular weight | 676.8 g/mol |
| Registered trials | 0 |
| PubChem CID | 24998056 |
Key takeaways
- Hexapeptide-11 has no FDA-approved label and is not authorized for any medical use.
- No registered clinical trials for hexapeptide-11 are currently listed.
- The compound has a molecular formula of C36H48N6O7 and a molecular weight of about 676.8.
- No adverse event reports are currently available for this compound.
What hexapeptide-11 is
Hexapeptide-11 is a synthetic peptide compound identified by PubChem CID 24998056. It has not been reviewed or approved by any regulatory agency, and no official drug label exists for it. Because it lacks an approved label, there is no established mechanism of action or indicated use to report. Hexapeptide-11 remains classified as a research compound only.
Trial footprint
There are currently no registered clinical trials for hexapeptide-11. This means there is no clinical trial evidence, from any phase, available to summarize for this compound at this time.
FAQ
No. Hexapeptide-11 has no FDA-approved label and is not authorized for any medical use. It is classified as a research compound.
There is no approved use for hexapeptide-11. No label or indication data exists for this compound in regulatory databases.
No clinical trials for hexapeptide-11 are currently registered. There is no clinical trial evidence available to describe at this time.
Hexapeptide-11 has the molecular formula C36H48N6O7 and a molecular weight of approximately 676.8. It is catalogued under PubChem CID 24998056.
No adverse event report data is currently available for hexapeptide-11. This reflects a lack of reported data rather than confirmation of safety.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 24998056 ClinicalTrials.gov registry count
Updated 2026-11-07